Is Neutrophil/Lymphocyte Ratio Associated with Subclinical Inflammation and Amyloidosis in Patients with Familial Mediterranean Fever?

Table 1

Baseline characteristics of patients with FMF.

	Patients; 𝑛=94
Age at diagnosis, (years)*	23.1 ± 12.8
Duration of illness, (years)*	6.6 ± 7.3
Family history of FMF, (𝑛, %)	54 (57.4)/42 (42.6)
Dose of colchicine, (mg/day)*	1.43 ± 0.55
Response to colchicine, (𝑛, %)	88 (93.6)/6 (6.4)
Scoring system of Pras et al. [10] (mild, moderate, severe)	5.44 ± 2.27
Fever, (𝑛, %)	87 (92.6)
Peritonitis, (𝑛, %)	87 (92.6)
Pleuritis, (𝑛, %)	58 (61.7)
Pericarditis, (𝑛, %)	8 (8.5)
Arthritis, (𝑛, %)	16 (17)
Arthralgia, (𝑛, %)	55 (58.5)
Myalgia, (𝑛, %)	44 (46.8)
Erysipelas-like erythema, (𝑛, %)	6 (6.4)
MEFV mutations, (𝑛, %)
Homozygous M694V	9 (9.6)
Heterozygous M694V	26 (27.7)
Heterozygous M680I	11 (11.7)
Heterozygous E148Q	11 (11.7)
Heterozygous V726A	4 (4.3)
Heterozygous M694V/M680I	4 (4.3)
Heterozygous M694V/E148Q	3 (3.2)
Others	26 (27.7)

∗Mean ± SD; [10] is reference number in the references section.